Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03873337 · ClinicalTrials.gov registry record · NA
Persistence Targeted Smoking Cessation in Serious Mental Illness (SMI)
A NA study, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- NA
- Development phase
- 34
- Enrollment target
NCT03873337 is a NA study that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 34 participants.
The verdict
NCT03873337, a NA study, has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
Study Summary
Due to the pandemic, this study was modified from a randomized clinical trial to test the feasibility, initial efficacy, and mechanisms of action of our PTSC-S intervention to a feasibility and acceptability test of our intervention when delivered via telehealth in a single group, within-subjects design.
Interventions
- DRUG Nicotine patch
- BEHAVIORAL Persistence Targeted Smoking Cessation in SMI (PTSC-S)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2019-04-22 |
| Est. Completion | 2022-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03873337
The ClinicalTrials.gov registry entry for NCT03873337 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Nicotine patch is the first listed.
NCT03873337 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03873337 about?
NCT03873337 is a clinical study titled "Persistence Targeted Smoking Cessation in Serious Mental Illness (SMI)". Due to the pandemic, this study was modified from a randomized clinical trial to test the feasibility, initial efficacy, and mechanisms of action of our PTSC-S intervention to a feasibility and acceptability test of our intervention when delivered via telehealth in a single group, within-subjects de...
What is the current status of trial NCT03873337?
This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2019-04-22. Estimated completion is 2022-01-31.
What interventions are being tested in trial NCT03873337?
The interventions under investigation include: Nicotine patch (DRUG), Persistence Targeted Smoking Cessation in SMI (PTSC-S) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03873337?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.